BBCR’s mission is to deliver cost-effective clinical plans and regulatory strategies for cell and gene therapy programs in the areas of rare disease.

Cell and Gene therapy are the new frontiers in the fight against devastating diseases, including rare diseases and cancers. Clinical trial results have been promising, and the next generation of Cell and Gene therapies holds tremendous promise for many patients and families.

We can assist with strategies that move products to market faster, including:

  • A cost-effective Clinical Plan that saves time and resources
  • Medical Monitoring
  • Ad-interim Chief Medical Monitor
  • Indications Selection and Prioritization
  • Trial Design and Protocol
  • Study Remediation and Rescue
  • Clinical research consultation for regulatory submissions and meetings
  • Program Gap Analyses

Learn more at


Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

Pin It on Pinterest